Victoza (liraglutide)

Victoza is a daily injection product containing liraglutide, made by Novo Nordisk. Its approved use in the U.S. is type 2 diabetes.

FDA-approved, but not for obesity

Educational information. This page does not give dosing instructions or tell you what to take. The current label and a prescriber decide that.

What Victoza is

Generic name: Liraglutide
Maker: Novo Nordisk
Form: Daily injection
U.S. approved use: Type 2 diabetes
First U.S. approval: 2010

How it differs from related products

Victoza contains liraglutide, the same drug as Saxenda. Its approved use is type 2 diabetes, not weight management. A prescriber using a diabetes-approved product to treat weight is using it off-label. This atlas does not advise on that.

Product	Form	U.S. approved use	Status
Saxenda	Daily injection	Weight management	FDA-approved for weight management
Victoza (this page)	Daily injection	Type 2 diabetes	FDA-approved, but not for obesity

What it is approved for

Type 2 diabetes. The current label lists the exact approved uses.

A prescriber using a diabetes-approved product to treat weight is using it off-label. This atlas does not advise on that, and its weight-loss figures are not from studies of this product.

How it is taken

Daily injection. Follow the current label and your prescriber for how to use it.

What the trials found

The weight-loss trial figures in this atlas come from studies of the weight-management products. They are not shown here because they were not studies of Victoza's approved use.

Safety

Warnings, side effects and open questions for liraglutide are on the liraglutide page. The official label is the controlling source.

Compiled from public information: FDA-approved labels, manufacturer websites, ClinicalTrials.gov and published journal articles. Sources are listed at the bottom of this page.

Liraglutide

The generic page: how it works, safety, and what is still unknown.

Saxenda

Saxenda and Victoza both contain liraglutide as a daily injection, but they are separate products with different approved uses.

Sources

Victoza (liraglutide) injection: prescribing information Novo Nordisk, on DailyMed (U.S. National Library of Medicine). Label version 10/2025. Official FDA label on DailyMed
DailyMed: current FDA drug labels U.S. National Library of Medicine. Regulator
Drugs@FDA: approved drug products U.S. Food and Drug Administration. Regulator